Personalized immune therapy: FAP as a marker for resistance to immune checkpoint therapy in urothelial carcinomas.
CRYPTIC TRANSCRIPTS: THE MASKED HEROES WHO BREAK TUMOR IMMUNE TOLERANCE AND FREE THE RESPONSE TO IMMUNE THERAPY.
Preclinical development of an innovative immune therapy based on CD56 + dendritic cells and interleukin-15: recruitment of the innate immune system in the fight against cancer.
Induction of multiple sclerosis (MS)-specific immune toleration using tolerogene dendritic cells and regulatory T cells. Preclinical evaluation of the therapeutic potential of cellular immune therapy in MS.
High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort
High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort
Prognosis and treatment of FOLFOX therapy related interstitial pneumonia : a plea for multimodal immune modulating therapy in the respiratory insufficient patient
Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapy
Lifespan extension with preservation of hippocampal function in aged system xc- - deficient male mice